Eccentric Cycling Exercise During Pulmonary Rehabilitation in Patients With Cardiopulmonary Diseases

June 19, 2025 updated by: Silvia Ulrich Somaini

Eccentric cycling exercise (ECC) allows training at low metabolic costs and may therefore be valuable for patients with pulmonary vascular disease (PVD). For these patients, regular exercise training has an evidence level 1A recommendation in the current guidelines. Exercise training during longer and regular periods provides chronic adaptation, for which ECC was recently found to have a greater effectiveness than CON by increasing muscle strength, hypertrophy, six-minute walking distance and furthermore, by increasing maximum oxygen uptake (V'O2max) especially in patients with chronic obstructive pulmonary disease (COPD), chronic left heart failure or coronary heart disease. Furthermore, we conducted an RCT in which we exposed patients with PVD to ECC and concluded that ECC is a feasible and well-tolerated exercise modality for PVD patients with severely lower O2 demand and load to the right ventricle. The study in patients with PVD was started (EccRehab), and the great potential was recognized. Therefore there was an indication to open the inclusion criteria to all cardiopulmonary patients with indication for pulmonary rehabilitation (EccRehab2).

For this purpose, the aim of this project is to investigate whether ECC improves exercise capacity and possibly hemodynamics during prolonged rehabilitation programs in patients with cardiopulmonary diseases.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with PVD, either PAH or CTEPH via right heart catheterization, according to recent guidelines [9]
  • Diagnosed with a cardiopulmonary disease as indication for a pulmonary rehabilitation
  • Stable medication for at least 1 month
  • Age 18years to 85 years
  • No resting hypoxemia (PaO2 >7.3 kPa)
  • Medical indication to prescibe a pulmonary rehabilitation

Exclusion Criteria:

  • Any co-morbidity that limits the patient to participate the full rehabilitation
  • Enrollments in other trials with active treatments
  • Language barriers that limits the patient to participate in the rehabilitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Eccentric cycling
Patients perform eccentric cycling exercise instead of normal cycling exercise in addition to standard car during a cardiopulmonary rehabilitation
Patients perform eccentric cycling exercise instead of normal cycling exercise in addition to standard car during a cardiopulmonary rehabilitation
Active Comparator: Standard care
Patients perform cardiopulmonary rehabilitation according to standard care
Patients perform cardiopulmonary rehabilitation according to standard care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak exercise performance [Watts]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
Peak exercise performance is measured during cardiopulmonary exercise tests on a cycle ergometer. The Unit of the measurement is watts.
At baseline pre-intervention and immediately after three weeks of rehabilitation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak oxygen uptake [L/min]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
Peak oxygen uptake is measured during cardiopulmonary exercise tests on a cycle ergometer. The Unit of the measurement is liters per minute.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Ventilatory equivalents for carbon dioxide (Minute ventilation / carbon dioxide output)
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
Ventilatory equivalents for carbon dioxide is measured during cardiopulmonary exercise tests on a cycle ergometer. The measurement is a ratio without a unit (VE/VCO2).
At baseline pre-intervention and immediately after three weeks of rehabilitation
Six minute walk distance [meters]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The maximal distance that a patient is able to walk within six minutes. The unit of the measurement is meters.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Knee extension test [repetitions]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The patients has to stad up from a chair and sit down as often the patient is able to do this within 1 minute. The unit of the measurement is repetitions.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Systolic pulmonary arterial pressure [mmHg]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The sytolic pulmonary arterial pressure is measured by echocardiography using continuous wave doppler at the tricuspid valve. The unit of the measurement is mmHg.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Total pulmonary reistance [Wood units]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The total pulmonary resistance is measured by echocardiography by dividing the systolic pulmonary arterial pressure by the cardiac output. The unit of the measurement is woos units.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Right ventricular to arterial coupling [mm/mmHg]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The right ventricular arterial coupling is measured by echocardiography dividing the tricuspid annular plane systolic excursion by the systolic arterial pressure. the unit is mm/mmHg.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Cardiac output [L/min]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The cardiac output is measured by echocardiography using the left ventricular outflow tract velocity time integral assessed by pulse wave doppler. The unit of the measurement is L/min.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Arterial partial pressure for oxygen [kPa]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The arterial partial pressure for oxygen is measured by taking a arterial blood sample from the arteria radialis at peak exercise and analyze it in a radiometer. The unit of the measurement is kPa.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Arterial partial pressure for carbon dioxide [kPa]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The arterial partial pressure for carbon dioxide is measured by taking a arterial blood sample from the arteria radialis at peak exercise and analyze it in a radiometer. The unit of the measurement is kPa.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Arterial oxygen saturation [%]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The arterial oxygen saturation is measured by taking a arterial blood sample from the arteria radialis at peak exercise and analyze it in a radiometer. The unit of the measurement is %.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Patient reported leg fatigue [scale from 1 to 10]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
Patients perceived leg fatigue is assessed at peak exercise on the Borg CR 10 scale. The unit of the measurement is a scale from 1 to 10.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Patient reported dyspnea [scale from 1 to 10]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
Patients perceived dyspnea is assessed at peak exercise on the Borg CR 10 scale. The unit of the measurement is a scale from 1 to 10.
At baseline pre-intervention and immediately after three weeks of rehabilitation
Patient reported quality of life [cm]
Time Frame: At baseline pre-intervention and immediately after three weeks of rehabilitation
The patient reported quality of life is assessed by the visual analogue scale, where the patient has to draw on a 10 cm long line where left is "bad" and right is "very good". The unit of the measurement is cm.
At baseline pre-intervention and immediately after three weeks of rehabilitation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2025

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

May 30, 2026

Study Registration Dates

First Submitted

June 10, 2025

First Submitted That Met QC Criteria

June 19, 2025

First Posted (Actual)

June 29, 2025

Study Record Updates

Last Update Posted (Actual)

June 29, 2025

Last Update Submitted That Met QC Criteria

June 19, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • EccRehab2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eccentric Exercise Training

Clinical Trials on Eccentric cycling exercise

Subscribe